Selected research
Industry Research
Rabies Diagnosis Industry Research Report 2026
Market perspective
The global Rabies Diagnosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Rabies Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Rabies Diagnosis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Rabies Diagnosis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Rabies Diagnosis include Bio-Rad Laboratories, Merck KGaA, Aviva Systems Biology, Creative Diagnostics, MyBioSource, Abbexa Ltd, Norgen Biotek and EXPRESS BIOTECH INTERNATIONAL, INC., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Rabies Diagnosis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Rabies Diagnosis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rabies Diagnosis Market by Company
Bio-Rad Laboratories
Merck KGaA
Aviva Systems Biology
Creative Diagnostics
MyBioSource
Abbexa Ltd
Norgen Biotek
EXPRESS BIOTECH INTERNATIONAL, INC.
Rabies Diagnosis Segment by Type
ELISA
PCR
Others
Rabies Diagnosis Segment by Application
Hospital
Clinic
Others
Rabies Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rabies Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Rabies Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA
- PCR
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Bio-Rad Laboratories
- Merck KGaA
- Aviva Systems Biology
- Creative Diagnostics
- MyBioSource
- Abbexa Ltd
- Norgen Biotek
- EXPRESS BIOTECH INTERNATIONAL, INC.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Rabies Diagnosis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 ELISA
- 2.2.3 PCR
- 2.2.4 Others
- 2.3 Rabies Diagnosis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Rabies Diagnosis Breakdown Data by Type
- 3.1 Global Rabies Diagnosis Historic Market Size by Type (2021-2026)
- 3.2 Global Rabies Diagnosis Forecasted Market Size by Type (2027-2032)
4 Rabies Diagnosis Breakdown Data by Application
- 4.1 Global Rabies Diagnosis Historic Market Size by Application (2021-2026)
- 4.2 Global Rabies Diagnosis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Rabies Diagnosis Market Perspective (2021-2032)
- 5.2 Global Rabies Diagnosis Growth Trends by Region
- 5.2.1 Global Rabies Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Rabies Diagnosis Historic Market Size by Region (2021-2026)
- 5.2.3 Rabies Diagnosis Forecasted Market Size by Region (2027-2032)
- 5.3 Rabies Diagnosis Market Dynamics
- 5.3.1 Rabies Diagnosis Industry Trends
- 5.3.2 Rabies Diagnosis Market Drivers
- 5.3.3 Rabies Diagnosis Market Challenges
- 5.3.4 Rabies Diagnosis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Rabies Diagnosis Players by Revenue
- 6.1.1 Global Top Rabies Diagnosis Players by Revenue (2021-2026)
- 6.1.2 Global Rabies Diagnosis Revenue Market Share by Players (2021-2026)
- 6.2 Global Rabies Diagnosis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Rabies Diagnosis Head Office and Area Served
- 6.4 Global Rabies Diagnosis Players, Product Type & Application
- 6.5 Global Rabies Diagnosis Manufacturers Established Date
- 6.6 Global Rabies Diagnosis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Rabies Diagnosis Market Size (2021-2032)
- 7.2 North America Rabies Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Rabies Diagnosis Market Size by Country (2021-2026)
- 7.4 North America Rabies Diagnosis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Rabies Diagnosis Market Size (2021-2032)
- 8.2 Europe Rabies Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Rabies Diagnosis Market Size by Country (2021-2026)
- 8.4 Europe Rabies Diagnosis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Rabies Diagnosis Market Size (2021-2032)
- 9.2 Asia-Pacific Rabies Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Rabies Diagnosis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Rabies Diagnosis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Rabies Diagnosis Market Size (2021-2032)
- 10.2 South America Rabies Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Rabies Diagnosis Market Size by Country (2021-2026)
- 10.4 South America Rabies Diagnosis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Rabies Diagnosis Market Size (2021-2032)
- 11.2 Middle East & Africa Rabies Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Rabies Diagnosis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Rabies Diagnosis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bio-Rad Laboratories
- 12.1.1 Bio-Rad Laboratories Company Information
- 12.1.2 Bio-Rad Laboratories Business Overview
- 12.1.3 Bio-Rad Laboratories Revenue in Rabies Diagnosis Business (2021-2026)
- 12.1.4 Bio-Rad Laboratories Rabies Diagnosis Product Portfolio
- 12.1.5 Bio-Rad Laboratories Recent Developments
- 12.2 Merck KGaA
- 12.2.1 Merck KGaA Company Information
- 12.2.2 Merck KGaA Business Overview
- 12.2.3 Merck KGaA Revenue in Rabies Diagnosis Business (2021-2026)
- 12.2.4 Merck KGaA Rabies Diagnosis Product Portfolio
- 12.2.5 Merck KGaA Recent Developments
- 12.3 Aviva Systems Biology
- 12.3.1 Aviva Systems Biology Company Information
- 12.3.2 Aviva Systems Biology Business Overview
- 12.3.3 Aviva Systems Biology Revenue in Rabies Diagnosis Business (2021-2026)
- 12.3.4 Aviva Systems Biology Rabies Diagnosis Product Portfolio
- 12.3.5 Aviva Systems Biology Recent Developments
- 12.4 Creative Diagnostics
- 12.4.1 Creative Diagnostics Company Information
- 12.4.2 Creative Diagnostics Business Overview
- 12.4.3 Creative Diagnostics Revenue in Rabies Diagnosis Business (2021-2026)
- 12.4.4 Creative Diagnostics Rabies Diagnosis Product Portfolio
- 12.4.5 Creative Diagnostics Recent Developments
- 12.5 MyBioSource
- 12.5.1 MyBioSource Company Information
- 12.5.2 MyBioSource Business Overview
- 12.5.3 MyBioSource Revenue in Rabies Diagnosis Business (2021-2026)
- 12.5.4 MyBioSource Rabies Diagnosis Product Portfolio
- 12.5.5 MyBioSource Recent Developments
- 12.6 Abbexa Ltd
- 12.6.1 Abbexa Ltd Company Information
- 12.6.2 Abbexa Ltd Business Overview
- 12.6.3 Abbexa Ltd Revenue in Rabies Diagnosis Business (2021-2026)
- 12.6.4 Abbexa Ltd Rabies Diagnosis Product Portfolio
- 12.6.5 Abbexa Ltd Recent Developments
- 12.7 Norgen Biotek
- 12.7.1 Norgen Biotek Company Information
- 12.7.2 Norgen Biotek Business Overview
- 12.7.3 Norgen Biotek Revenue in Rabies Diagnosis Business (2021-2026)
- 12.7.4 Norgen Biotek Rabies Diagnosis Product Portfolio
- 12.7.5 Norgen Biotek Recent Developments
- 12.8 EXPRESS BIOTECH INTERNATIONAL, INC.
- 12.8.1 EXPRESS BIOTECH INTERNATIONAL, INC. Company Information
- 12.8.2 EXPRESS BIOTECH INTERNATIONAL, INC. Business Overview
- 12.8.3 EXPRESS BIOTECH INTERNATIONAL, INC. Revenue in Rabies Diagnosis Business (2021-2026)
- 12.8.4 EXPRESS BIOTECH INTERNATIONAL, INC. Rabies Diagnosis Product Portfolio
- 12.8.5 EXPRESS BIOTECH INTERNATIONAL, INC. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst